R. Stupp, W. P. Mason, M. J. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, pp.987-96, 2005.

C. Vijapura, E. Saad-aldin, A. A. Capizzano, B. Policeni, Y. Sato et al., Genetic syndromes associated with central nervous system tumors, Radiographics, vol.37, pp.258-80, 2017.

M. L. Bondy, M. E. Scheurer, B. Malmer, J. S. Barnholtz-sloan, F. G. Davis et al., Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium, Cancer, vol.113, pp.1953-68, 2008.

E. Linos, T. Raine, A. Alonso, and D. Michaud, Atopy and risk of brain tumors: a meta-analysis, J Natl Cancer Inst, vol.99, pp.1544-50, 2007.

C. Lu-emerson, D. G. Duda, K. E. Emblem, J. W. Taylor, E. R. Gerstner et al., Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma, J Clin Oncol, vol.33, pp.1197-213, 2015.

O. L. Chinot, W. Wick, W. Mason, R. Henriksson, F. Saran et al., Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma, N Engl J Med, vol.370, pp.709-731, 2014.

H. S. Friedman, M. D. Prados, P. Y. Wen, T. Mikkelsen, D. Schiff et al., Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma, J Clin Oncol, vol.27, pp.4733-4773, 2009.

A. Ghiaseddin and K. B. Peters, Use of bevacizumab in recurrent glioblastoma, CNS Oncol, vol.4, pp.157-69, 2015.

K. K. Jain, A critical overview of targeted therapies for glioblastoma, Front Oncol, vol.8, p.419, 2018.

J. D. Lathia, S. C. Mack, E. E. Mulkearns-hubert, C. Valentim, and J. N. Rich, Cancer stem cells in glioblastoma, Genes Dev, vol.29, pp.1203-1220, 2015.

R. C. Gimple, S. Bhargava, D. Dixit, and J. N. Rich, Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer, Genes Dev, vol.33, pp.591-609, 2019.

B. T. Pan, K. Teng, C. Wu, M. Adam, and R. M. Johnstone, Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes, J Cell Biol, vol.101, pp.942-950, 1985.

J. C. Akers, D. Gonda, R. Kim, B. S. Carter, and C. C. Chen, Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retroviruslike vesicles, and apoptotic bodies, J Neurooncol, vol.113, pp.1-11, 2013.

S. Gandham, X. Su, J. Wood, A. L. Nocera, S. C. Alli et al., Technologies and standardization in research on extracellular vesicles, Trends Biotechnol, 2020.

C. Théry, K. W. Witwer, E. Aikawa, M. J. Alcaraz, J. D. Anderson et al., Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, J Extracell Vesicles, vol.7, p.1535750, 2018.

J. Escola, M. J. Kleijmeer, W. Stoorvogel, J. M. Griffith, Y. O. Geuze et al., Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes, J Biol Chem, vol.273, pp.20121-20128, 1998.

R. Wubbolts, R. S. Leckie, P. Veenhuizen, G. Schwarzmann, W. Möbius et al., Proteomic and biochemical analyses of human B cell-derived exosomes: potential implications for their function and multivesicular body formatION, J Biol Chem, vol.278, pp.10963-72, 2003.

G. Van-niel, D. Angelo, G. Raposo, and G. , Shedding light on the cell biology of extracellular vesicles, Nat Rev Mol Cell Biol, vol.19, pp.213-241, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02359760

E. Nolte-'t-hoen, H. Buermans, M. Waasdorp, W. Stoorvogel, M. Wauben et al., Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions, Nucleic Acids Res, vol.40, pp.9272-85, 2012.

J. Skog, T. Würdinger, S. Van-rijn, D. H. Meijer, L. Gainche et al., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nat Cell Biol, vol.10, pp.1470-1476, 2008.

A. M. Weaver and J. G. Patton, Argonautes in extracellular vesicles: artifact or selected cargo?, Cancer Res, vol.80, pp.379-81, 2020.

J. Van-deun, P. Mestdagh, R. Sormunen, V. Cocquyt, K. Vermaelen et al., The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling, J Extracell Vesicles, vol.3, p.24858, 2014.

D. K. Jeppesen, A. M. Fenix, J. L. Franklin, J. N. Higginbotham, Q. Zhang et al., Reassessment of exosome composition, Cell, vol.177, pp.428-473, 2019.

S. A. Bellingham, B. M. Coleman, and A. F. Hill, Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells, Nucleic Acids Res, vol.40, pp.10937-10986, 2012.

K. Laulagnier, C. Motta, S. Hamdi, S. Roy, F. Fauvelle et al., Mast cell-and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization, Biochem J, vol.380, pp.161-71, 2004.

C. Subra, K. Laulagnier, B. Perret, and M. Record, Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie, vol.89, pp.205-217, 2007.

T. Skotland, K. Sagini, K. Sandvig, and A. Llorente, An emerging focus on lipids in extracellular vesicles, Adv Drug Deliv Rev, 2020.

C. Williams, F. Royo, O. Aizpurua-olaizola, R. Pazos, G. Boons et al., Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives, J Extracell Vesicles, vol.7, p.1442985, 2018.

C. Gardiner, D. D. Vizio, S. Sahoo, C. Théry, K. W. Witwer et al., Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey, J Extracell Vesicles, vol.5, p.32945, 2016.

E. Consortium, J. Van-deun, P. Mestdagh, P. Agostinis, Ö. Akay et al., EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research, Nat Methods, vol.14, pp.228-260, 2017.

G. André-grégoire and J. Gavard, Spitting out the demons: extracellular vesicles in glioblastoma, Cell Adhes Migr, vol.11, pp.164-72, 2017.

K. Al-nedawi, B. Meehan, J. Micallef, V. Lhotak, L. May et al., Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, Nat Cell Biol, vol.10, pp.619-643, 2008.

K. R. Pace, R. Dutt, and D. S. Galileo, Exosomal L1CAM stimulates glioblastoma cell motility, proliferation, and invasiveness, Int J Mol Sci, vol.20, p.3982, 2019.

J. H. An, S. Y. Lee, J. Y. Jeon, K. G. Cho, S. U. Kim et al., Identification of gliotropic factors that induce human stem cell migration to malignant tumor, J Proteome Res, vol.8, pp.2873-81, 2009.

A. Bronisz, Y. Wang, M. O. Nowicki, P. Peruzzi, K. I. Ansari et al., Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1, Cancer Res, vol.74, pp.738-50, 2014.

J. Son, C. A. Lyssiotis, H. Ying, X. Wang, S. Hua et al., Glutamine supports pancreatic cancer growth through a KRASregulated metabolic pathway, Nature, vol.496, pp.101-106, 2013.

A. Yekula, V. R. Minciacchi, M. Morello, H. Shao, Y. Park et al., Large and small extracellular vesicles released by glioma cells in vitro and in vivo, J Extracell Vesicles, vol.9, p.1689784, 2020.

M. S. Pavlyukov, H. Yu, S. Bastola, M. Minata, V. O. Shender et al., Apoptotic cell-derived extracellular vesicles promote malignancy of glioblastoma via intercellular transfer of splicing factors, Cancer Cell, vol.34, pp.119-154, 2018.

J. Figueroa, L. M. Phillips, T. Shahar, A. Hossain, J. Gumin et al., Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR-1587, Cancer Res, vol.77, pp.5808-5827, 2017.

D. Li, Y. Tian, Y. Hu, Y. Qi, N. Tian et al., Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9, Oncogene, vol.38, pp.6898-912, 2019.

J. Berenguer, T. Lagerweij, X. W. Zhao, S. Dusoswa, P. Van-der-stoop et al., Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8, J Extracell Vesicles, vol.7, p.1446660, 2018.

S. A. Dusoswa, S. K. Horrevorts, M. Ambrosini, H. Kalay, N. J. Paauw et al., Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells, J Extracell Vesicles, vol.8, p.1648995, 2019.

L. Treps, S. Edmond, E. Harford-wright, E. M. Galan-moya, A. Schmitt et al., Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma, Oncogene, vol.35, pp.2615-2638, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01406334

L. Treps, R. Perret, S. Edmond, R. D. Gavard, and J. , Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles, J Extracell Vesicles, vol.6, p.1359479, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01573268

R. Lucero, V. Zappulli, A. Sammarco, O. D. Murillo, P. S. Cheah et al., Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells, Cell Rep, vol.30, pp.2065-74, 2020.

P. Kucharzewska, H. C. Christianson, J. E. Welch, K. J. Svensson, E. Fredlund et al., Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development, Proc Natl Acad Sci, vol.110, pp.7312-7319, 2013.

S. Hallal, D. M. Mallawaaratchy, H. Wei, S. Ebrahimkhani, B. W. Stringer et al., Extracellular vesicles released by glioblastoma cells stimulate normal astrocytes to acquire a tumorsupportive phenotype via p53 and MYC signaling pathways, Mol Neurobiol, vol.56, pp.4566-81, 2019.

S. Oushy, J. E. Hellwinkel, M. Wang, G. J. Nguyen, D. Gunaydin et al., Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype, Philos Trans R Soc B, vol.373, 2018.

N. W. Colangelo and E. I. Azzam, Extracellular vesicles originating from glioblastoma cells increase metalloproteinase release by astrocytes: the role of CD147 (EMMPRIN) and ionizing radiation, Cell Commun Signal, vol.18, p.21, 2020.

J. De-vrij, S. Maas, K. Kwappenberg, R. Schnoor, A. Kleijn et al., Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells: glioblastoma vesicles affect monocytic cells, Int J Cancer, vol.137, pp.1630-1672, 2015.

K. E. Van-der-vos, E. R. Abels, X. Zhang, C. Lai, E. Carrizosa et al., Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain, Neuro Oncol, vol.18, pp.58-69, 2016.

B. T. Himes, T. E. Peterson, T. De-mooij, L. Garcia, M. Jung et al., The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction, Neuro Oncol, vol.22, pp.967-78, 2020.

R. Domenis, D. Cesselli, B. Toffoletto, E. Bourkoula, F. Caponnetto et al., Systemic T cells immunosuppression of glioma stem cell-derived exosomes is mediated by monocytic myeloidderived suppressor cells, PLoS ONE, vol.12, p.169932, 2017.

X. Guo, W. Qiu, J. Wang, Q. Liu, M. Qian et al., Glioma exosomes mediate the expansion and function of myeloid-derived suppressor cells through microRNA-29a/Hbp1 and microRNA-92a/Prkar1a pathways, Int J Cancer, vol.144, pp.3111-3137, 2019.

H. Shao, J. Chung, K. Lee, L. Balaj, C. Min et al., Chipbased analysis of exosomal mRNA mediating drug resistance in glioblastoma, Nat Commun, vol.6, p.6999, 2015.

T. Yu, X. Wang, T. Zhi, J. Zhang, Y. Wang et al., Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype, Cancer Lett, vol.433, pp.210-230, 2018.

M. Bebawy, V. Combes, E. Lee, R. Jaiswal, J. Gong et al., Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells, Leukemia, vol.23, pp.1643-1652, 2009.

J. Yin, A. Zeng, Z. Zhang, Z. Shi, W. Yan et al., Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma, EBioMedicine, vol.42, pp.238-51, 2019.

E. C. Cosset, J. Godet, N. Entz-werlé, E. Guérin, D. Guenot et al., Involvement of the TGF? pathway in the regulation of ?5?1 integrins by caveolin-1 in human glioblastoma, Int J Cancer, vol.131, pp.601-612, 2012.

J. Yang, Y. Tong, J. Jing, S. , F. B. Wang et al., Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma, J Neurooncol, vol.131, pp.255-65, 2017.

C. Zhang, J. Zhang, A. Zhang, Z. Shi, L. Han et al., MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma, Mol Cancer, vol.9, p.229, 2010.

Z. Zhang, J. Yin, C. Lu, Y. Wei, A. Zeng et al., Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma, J Exp Clin Cancer Res, vol.38, p.166, 2019.

T. Simon, S. Pinioti, P. Schellenberger, V. Rajeeve, F. Wendler et al., Shedding of bevacizumab in tumour cellsderived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma, Mol Cancer, vol.17, p.132, 2018.

X. Yue, F. Lan, and T. Xia, Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt/?-catenin signaling and promotes radiation resistance by targeting TCEAL7, Mol Ther, vol.27, pp.1939-1988, 2019.

G. Andre-gregoire, N. Bidere, and J. Gavard, Temozolomide affects extracellular vesicles released by glioblastoma cells, Biochimie, vol.155, pp.11-16, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01715956

D. Garnier, B. Meehan, T. Kislinger, P. Daniel, A. Sinha et al., Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization, Neuro Oncol, vol.20, pp.236-284, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01814308

V. Ramakrishnan, B. Xu, J. Akers, T. Nguyen, J. Ma et al., Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas, EBioMedicine, vol.55, p.102736, 2020.

D. Osti, D. Bene, M. Rappa, G. Santos, M. Matafora et al., Clinical significance of extracellular vesicles in plasma from glioblastoma patients, Clin Cancer Res, vol.25, pp.266-76, 2019.

H. Zhang and D. Lyden, Asymmetric-flow field-flow fractionation technology for exomere and small extracellular vesicle separation and characterization, Nat Protoc, vol.14, pp.1027-53, 2019.

H. Zhang, D. Freitas, H. S. Kim, K. Fabijanic, Z. Li et al., Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation, Nat Cell Biol, vol.20, pp.332-375, 2018.

S. Hallal, A. Azimi, H. Wei, N. Ho, M. Lee et al., A comprehensive proteomic SWATH-MS workflow for profiling blood extracellular vesicles: a new avenue for glioma tumour surveillance, Int J Mol Sci, vol.21, p.4754, 2020.

I. Chandran, V. Welinder, C. Månsson, A. Offer, S. Freyhult et al., Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies Syndecan-1 as a potential tool for minimally invasive diagnosis of glioma, Clin Cancer Res, vol.25, pp.3115-3142, 2019.

J. Godlewski, R. Ferrer-luna, A. K. Rooj, M. Mineo, F. Ricklefs et al., MicroRNA signatures and molecular subtypes of glioblastoma: the role of extracellular transfer, Stem Cell Rep, vol.8, pp.1497-505, 2017.

S. Ebrahimkhani, F. Vafaee, S. Hallal, H. Wei, M. Lee et al., Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis, Precis Oncol, vol.2, p.28, 2018.

S. K. Tan, C. Pastori, C. Penas, R. J. Komotar, M. E. Ivan et al., Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme, Mol Cancer, vol.17, p.74, 2018.

J. M. Figueroa, J. Skog, J. Akers, H. Li, R. Komotar et al., Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients, Neuro Oncol, vol.19, pp.1494-502, 2017.

J. A. Saugstad, T. A. Lusardi, K. R. Van-keuren-jensen, J. I. Phillips, B. Lind et al., Analysis of extracellular RNA in cerebrospinal fluid, J Extracell Vesicles, vol.6, p.1317577, 2017.

S. V. Manda, Y. Kataria, B. R. Tatireddy, B. Ramakrishnan, B. G. Ratnam et al., Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas, J Neurosurg, vol.128, pp.1091-101, 2018.

S. M. Evans, M. Putt, X. Yang, R. A. Lustig, M. Martinez-lage et al., Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients, J Neurooncol, vol.127, pp.391-400, 2016.

F. Lan, Q. Qing, Q. Pan, M. Hu, H. Yu et al., Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma, Cell Oncol, vol.41, pp.25-33, 2018.